<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mvjr</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский вестник Юга России</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Herald of the South of Russia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2219-8075</issn><issn pub-type="epub">2618-7876</issn><publisher><publisher-name>The Rostov State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21886/2219-8075-2025-16-4-74-83</article-id><article-id custom-type="elpub" pub-id-type="custom">mvjr-2073</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ИНФЕКЦИОННЫЕ БОЛЕЗНИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>INFECTIOUS DISEASES</subject></subj-group></article-categories><title-group><article-title>Современные направления изучения средств неспецифической профилактики холеры</article-title><trans-title-group xml:lang="en"><trans-title>Modern approaches to studying non-specific prevention of cholera</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1103-4244</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Филиппенко</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Filippenko</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Филиппенко Анна Владимировна, к.б.н., научный сотрудник лаборатории иммунологии</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Anna V. Filippenko, Cand. Sci. (Biology), Research Laboratory of Immunology</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">filippenko.annushka@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7068-4071</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Иванова</surname><given-names>И. И</given-names></name><name name-style="western" xml:lang="en"><surname>Ivanova</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Иванова Инна Александровна, к.б.н., ведущий научный сотрудник, и.о. зав. лабораторией иммунологии</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Inna A. Ivanova, Cand. Sci. (Biology), Leading Researcher with Acting Head of the Laboratory Immunology</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">ivanova_ia@antiplague.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5208-7724</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Омельченко</surname><given-names>Н. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Omelchenko</surname><given-names>N. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Омельченко Наталья Дмитриевна, к.м.н., старший научный сотрудник лаборатории иммунологии</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Natalia D. Omelchenko, Cand. Sci. (Med.), Senior Researcher Laboratory of Immunology</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">natalya.omelchenko@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4770-5994</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Труфанова</surname><given-names>А. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Trufanova</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Труфанова Анастасия Александровна, младший научный сотрудник лаборатории иммунологии</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Anastasia A. Trufanova, Junior Researcher, Laboratory of Immunology</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">nastyasia61@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-3926-8182</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жукова</surname><given-names>О. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhukova</surname><given-names>O. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Жукова Ольга Геннадьевна, младший научный сотрудник лаборатории иммунологии</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Olga G. Zhukova, Junior Researcher at the Laboratory of Immunology</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">zhuova_og@antiplague.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Ростовский-на-Дону противочумный институт Роспотребнадзора</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Rostov-on-Don Anti-Plague Institute of Rospotrebnadzor</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>21</day><month>12</month><year>2025</year></pub-date><volume>16</volume><issue>4</issue><fpage>74</fpage><lpage>83</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Филиппенко А.В., Иванова И.И., Омельченко Н.Д., Труфанова А.Д., Жукова О.Г., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Филиппенко А.В., Иванова И.И., Омельченко Н.Д., Труфанова А.Д., Жукова О.Г.</copyright-holder><copyright-holder xml:lang="en">Filippenko A.V., Ivanova I.A., Omelchenko N.D., Trufanova A.A., Zhukova O.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.medicalherald.ru/jour/article/view/2073">https://www.medicalherald.ru/jour/article/view/2073</self-uri><abstract><p>Холера остается серьезной проблемой общественного здравоохранения, особенно в странах с низким уровнем доходов, отсутствием водоснабжения и санитарно-просветительного образования среди населения. Вакцинация на сегодняшний день является основной мерой профилактики этой инфекции в эндемичных районах и во время вспышек, однако по ряду причин её эффективность может снижаться: всегда есть группа лиц, имеющих противопоказания к проведению вакцинации и не отвечающих на вакцину. Кроме того, существуют проблемы с доставкой, хранением и транспортировкой вакцинных препаратов. Все эти факторы обусловливают необходимость поиска, разработки и внедрения различных новых средств, препятствующих распространению заболевания. Целью данного обзора являлся анализ литературных данных, посвящённых изучению возможности использования антибиотиков, бактериофагов, пробиотических микроорганизмов, растительных компонентов и других веществ, для профилактики холеры. Список литературы включает 56 источников за последние десять лет, взятых из баз данных «РИНЦ», «eLibrary», «MedLine», «PubMed».</p></abstract><trans-abstract xml:lang="en"><p>Cholera remains a serious public health problem, especially in low-income countries with a lack of water supply and sanitation education among the population. Vaccination is currently the main measure to prevent this infection in endemic areas and during outbreaks, but for a number of reasons its effectiveness may decrease: there is always a group of people who have contraindications to vaccination and do not respond to the vaccine. In addition, there are problems with the delivery, storage and transportation of vaccine preparations. All these factors necessitate the search, development and implementation of various new means to prevent the spread of the disease. The purpose of this review was to analyze the literature data on the study of the possibility of using antibiotics, bacteriophages, probiotic microorganisms, plant components and other substances for the prevention of cholera. The list of references includes 56 sources for the last ten years, taken from databases: RSCI, eLibrary, MedLine, PubMed.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>обзор</kwd><kwd>холера</kwd><kwd>неспецифическая профилактика</kwd><kwd>бактериофаги</kwd><kwd>пробиотики</kwd><kwd>растительные&#13;
компоненты</kwd></kwd-group><kwd-group xml:lang="en"><kwd>overview</kwd><kwd>cholera</kwd><kwd>nonspecific prophylaxis</kwd><kwd>bacteriophages</kwd><kwd>probiotics</kwd><kwd>herbal components</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование не имело спонсорской поддержки.</funding-statement><funding-statement xml:lang="en">The study did not have sponsorship.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Dias RA. Towards a Comprehensive Definition of Pandemics and Strategies for Prevention: A Historical Review and Future Perspectives. Microorganisms. 2024;12(9):1802. https://doi.org/10.3390/microorganisms12091802</mixed-citation><mixed-citation xml:lang="en">Dias RA. Towards a Comprehensive Definition of Pandemics and Strategies for Prevention: A Historical Review and Future Perspectives. Microorganisms. 2024;12(9):1802. https://doi.org/10.3390/microorganisms12091802</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ojeda Rodriguez JA, Hashmi MF, Kahwaji CI. Vibrio cholerae Infection. 2024. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. PMID: 30252355.</mixed-citation><mixed-citation xml:lang="en">Ojeda Rodriguez JA, Hashmi MF, Kahwaji CI. Vibrio cholerae Infection. 2024. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. PMID: 30252355.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Hsueh BY, Waters CM. Combating Cholera. F1000Res. 2019;8:F1000 Faculty Rev-589. https://doi.org/10.12688/f1000research.18093.1</mixed-citation><mixed-citation xml:lang="en">Hsueh BY, Waters CM. Combating Cholera. F1000Res. 2019;8:F1000 Faculty Rev-589. https://doi.org/10.12688/f1000research.18093.1</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Eneh S, Onukansi F, Anokwuru C, Ikhuoria O, Edeh G, et al. Cholera outbreak trends in Nigeria: policy recommendations and innovative approaches to prevention and treatment. Front Public Health. 2024;12:1464361. https://doi.org/10.3389/fpubh.2024.1464361</mixed-citation><mixed-citation xml:lang="en">Eneh S, Onukansi F, Anokwuru C, Ikhuoria O, Edeh G, et al. Cholera outbreak trends in Nigeria: policy recommendations and innovative approaches to prevention and treatment. Front Public Health. 2024;12:1464361. https://doi.org/10.3389/fpubh.2024.1464361</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Chowdhury F, Ross AG, Islam MT, McMillan NAJ, Qadri F. Diagnosis, Management, and Future Control of Cholera. Clin Microbiol Rev. 2022;35(3):e0021121. https://doi.org/10.1128/cmr.00211-21</mixed-citation><mixed-citation xml:lang="en">Chowdhury F, Ross AG, Islam MT, McMillan NAJ, Qadri F. Diagnosis, Management, and Future Control of Cholera. Clin Microbiol Rev. 2022;35(3):e0021121. https://doi.org/10.1128/cmr.00211-21</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Кретенчук О.Ф., Полеева М.В., Коршенко В.А., Марковская Е.И., Чемисова О.С. Эффективные средства в борьбе с холерой в эпоху антибиотикорезистентности. Вестник биотехнологии и физико-химической биологии им. Ю.А. Овчинникова. 2022;18(4):72-82.</mixed-citation><mixed-citation xml:lang="en">Kretenchuk O.F., Poleeva M.V., Korshenko V.A., Markovskaya E.I., Chemisova O.S. Effective means in the fight against cholera in the era of antibiotic resistance. Vestnik biotekhnologii i fiziko-khimicheskoi biologii im. YU.A. Ovchinnikova. 2022;18(4):72-82. (In Russ.) eLIBRARY ID: 54044500 EDN: UQIFMH</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kunkel A, Lewnard JA, Pitzer VE, Cohen T. Antimicrobial Resistance Risks of Cholera Prophylaxis for United Nations Peacekeepers. Antimicrob Agents Chemother. 2017;61(8):e00026-17. https://doi.org/10.1128/AAC.00026-17</mixed-citation><mixed-citation xml:lang="en">Kunkel A, Lewnard JA, Pitzer VE, Cohen T. Antimicrobial Resistance Risks of Cholera Prophylaxis for United Nations Peacekeepers. Antimicrob Agents Chemother. 2017;61(8):e00026-17. https://doi.org/10.1128/AAC.00026-17</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Mazzantini D, Calvigioni M, Celandroni F, Lupetti A, Ghelardi E. Spotlight on the Compositional Quality of Probiotic Formulations Marketed Worldwide. Front Microbiol. 2021;12:693973. https://doi.org/10.3389/fmicb.2021.693973</mixed-citation><mixed-citation xml:lang="en">Mazzantini D, Calvigioni M, Celandroni F, Lupetti A, Ghelardi E. Spotlight on the Compositional Quality of Probiotic Formulations Marketed Worldwide. Front Microbiol. 2021;12:693973. https://doi.org/10.3389/fmicb.2021.693973</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Flaugnatti N, Isaac S, Lemos Rocha LF, Stutzmann S, Rendueles O, et al. Human commensal gut Proteobacteria withstand type VI secretion attacks through immunity proteinindependent mechanisms. Nat Commun. 2021;12(1):5751. https://doi.org/10.1038/s41467-021-26041-0</mixed-citation><mixed-citation xml:lang="en">Flaugnatti N, Isaac S, Lemos Rocha LF, Stutzmann S, Rendueles O, et al. Human commensal gut Proteobacteria withstand type VI secretion attacks through immunity proteinindependent mechanisms. Nat Commun. 2021;12(1):5751. https://doi.org/10.1038/s41467-021-26041-0</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Cruz KCP, Enekegho LO, Stuart DT. Bioengineered Probiotics: Synthetic Biology Can Provide Live Cell Therapeutics for the Treatment of Foodborne Diseases. Front Bioeng Biotechnol. 2022;10:890479. https://doi.org/10.3389/fbioe.2022.890479</mixed-citation><mixed-citation xml:lang="en">Cruz KCP, Enekegho LO, Stuart DT. Bioengineered Probiotics: Synthetic Biology Can Provide Live Cell Therapeutics for the Treatment of Foodborne Diseases. Front Bioeng Biotechnol. 2022;10:890479. https://doi.org/10.3389/fbioe.2022.890479</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Mathipa MG, Thantsha MS. Probiotic engineering: towards development of robust probiotic strains with enhanced functional properties and for targeted control of enteric pathogens. Gut Pathog. 2017;9:28. https://doi.org/10.1186/s13099-017-0178-9</mixed-citation><mixed-citation xml:lang="en">Mathipa MG, Thantsha MS. Probiotic engineering: towards development of robust probiotic strains with enhanced functional properties and for targeted control of enteric pathogens. Gut Pathog. 2017;9:28. https://doi.org/10.1186/s13099-017-0178-9</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Asadi M, Fazeli MR, Sabokbar A. Growth Inhibitory Effect of Lactocare on Vibrio cholerae. Iran J Pathol. 2018;13(3):301-307. PMID: 30636952; PMCID: PMC6322523.</mixed-citation><mixed-citation xml:lang="en">Asadi M, Fazeli MR, Sabokbar A. Growth Inhibitory Effect of Lactocare on Vibrio cholerae. Iran J Pathol. 2018;13(3):301-307. PMID: 30636952; PMCID: PMC6322523.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Mao N, Cubillos-Ruiz A, Cameron DE, Collins JJ. Probiotic strains detect and suppress cholera in mice. Sci Transl Med. 2018;10(445):eaao2586. https://doi.org/10.1126/scitranslmed.aao2586</mixed-citation><mixed-citation xml:lang="en">Mao N, Cubillos-Ruiz A, Cameron DE, Collins JJ. Probiotic strains detect and suppress cholera in mice. Sci Transl Med. 2018;10(445):eaao2586. https://doi.org/10.1126/scitranslmed.aao2586</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kaur S, Sharma P, Kalia N, Singh J, Kaur S. Anti-biofilm Properties of the Fecal Probiotic Lactobacilli Against Vibrio spp. Front Cell Infect Microbiol. 2018;8:120. https://doi.org/10.3389/fcimb.2018.00120</mixed-citation><mixed-citation xml:lang="en">Kaur S, Sharma P, Kalia N, Singh J, Kaur S. Anti-biofilm Properties of the Fecal Probiotic Lactobacilli Against Vibrio spp. Front Cell Infect Microbiol. 2018;8:120. https://doi.org/10.3389/fcimb.2018.00120</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Weil AA, Becker RL, Harris JB. Vibrio cholerae at the Intersection of Immunity and the Microbiome. mSphere. 2019;4(6):e00597-19. https://doi.org/10.1128/mSphere.00597-19</mixed-citation><mixed-citation xml:lang="en">Weil AA, Becker RL, Harris JB. Vibrio cholerae at the Intersection of Immunity and the Microbiome. mSphere. 2019;4(6):e00597-19. https://doi.org/10.1128/mSphere.00597-19</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Buatong A, Meidong R, Trongpanich Y, Tongpim S. Production of plant-based fermented beverages possessing functional ingredients antioxidant, γ-aminobutyric acid and antimicrobials using a probiotic Lactiplantibacillus plantarum strain L42g as an efficient starter culture. J Biosci Bioeng. 2022;134(3):226-232. https://doi.org/10.1016/j.jbiosc.2022.05.008</mixed-citation><mixed-citation xml:lang="en">Buatong A, Meidong R, Trongpanich Y, Tongpim S. Production of plant-based fermented beverages possessing functional ingredients antioxidant, γ-aminobutyric acid and antimicrobials using a probiotic Lactiplantibacillus plantarum strain L42g as an efficient starter culture. J Biosci Bioeng. 2022;134(3):226-232. https://doi.org/10.1016/j.jbiosc.2022.05.008</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Derakhshan-Sefidi M, Bakhshi B, Rasekhi A. Vibriocidal efficacy of Bifidobacterium bifidum and Lactobacillus acidophilus cell-free supernatants encapsulated in chitosan nanoparticles against multi-drug resistant Vibrio cholerae O1 El Tor. BMC Infect Dis. 2024;24(1):905. https://doi.org/10.1186/s12879-024-09810-2</mixed-citation><mixed-citation xml:lang="en">Derakhshan-Sefidi M, Bakhshi B, Rasekhi A. Vibriocidal efficacy of Bifidobacterium bifidum and Lactobacillus acidophilus cell-free supernatants encapsulated in chitosan nanoparticles against multi-drug resistant Vibrio cholerae O1 El Tor. BMC Infect Dis. 2024;24(1):905. https://doi.org/10.1186/s12879-024-09810-2</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Alavi S, Mitchell JD, Cho JY, Liu R, Macbeth JC, Hsiao A. Interpersonal Gut Microbiome Variation Drives Susceptibility and Resistance to Cholera Infection. Cell. 2020;181(7):1533- 1546.e13. https://doi.org/10.1016/j.cell.2020.05.036</mixed-citation><mixed-citation xml:lang="en">Alavi S, Mitchell JD, Cho JY, Liu R, Macbeth JC, Hsiao A. Interpersonal Gut Microbiome Variation Drives Susceptibility and Resistance to Cholera Infection. Cell. 2020;181(7):1533- 1546.e13. https://doi.org/10.1016/j.cell.2020.05.036</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Han Z, Min Y, Pang K, Wu D. Therapeutic Approach Targeting Gut Microbiome in Gastrointestinal Infectious Diseases. Int J Mol Sci. 2023;24(21):15654. https://doi.org/10.3390/ijms242115654</mixed-citation><mixed-citation xml:lang="en">Han Z, Min Y, Pang K, Wu D. Therapeutic Approach Targeting Gut Microbiome in Gastrointestinal Infectious Diseases. Int J Mol Sci. 2023;24(21):15654. https://doi.org/10.3390/ijms242115654</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Bhandare S, Colom J, Baig A, Ritchie JM, Bukhari H, et al. Reviving Phage Therapy for the Treatment of Cholera. J Infect Dis. 2019;219(5):786-794. https://doi.org/10.1093/infdis/jiy563</mixed-citation><mixed-citation xml:lang="en">Bhandare S, Colom J, Baig A, Ritchie JM, Bukhari H, et al. Reviving Phage Therapy for the Treatment of Cholera. J Infect Dis. 2019;219(5):786-794. https://doi.org/10.1093/infdis/jiy563</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Chaudhary N, Mohan B, Kaur H, Modgil V, Kant V, et al. Vibrio Phage VMJ710 Can Prevent and Treat Disease Caused by Pathogenic MDR V. cholerae O1 in an Infant Mouse Model. Antibiotics (Basel). 2023;12(6):1046. https://doi.org/10.3390/antibiotics12061046</mixed-citation><mixed-citation xml:lang="en">Chaudhary N, Mohan B, Kaur H, Modgil V, Kant V, et al. Vibrio Phage VMJ710 Can Prevent and Treat Disease Caused by Pathogenic MDR V. cholerae O1 in an Infant Mouse Model. Antibiotics (Basel). 2023;12(6):1046. https://doi.org/10.3390/antibiotics12061046</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Тюрина А.В., Гаевская Н.Е., Селянская Н.А., Егиазарян Л.А., Погожова М.П., и др. Активность препарата бактериофагов в отношении антибиотикорезистентных штаммов холерных вибрионов El Tor. Антибиотики и Химиотерапия. 2018;63(7-8):29-32.</mixed-citation><mixed-citation xml:lang="en">Tyurina A.V., Gaevskaya N.E., Selyanskaya N.A., Egiazaryan L.A., Pogozhova M.P., et al. Activity of Bacteriophage Preparation in Relation to Antibiotic-Resistant El Tor Strain of Vibrio Cholerae. Antibiotiki i Khimioterapiya = Antibiotics and Chemotherapy. 2018;63(7-8):29-32. (In Russ.) eLIBRARY ID: 36551700 EDN: SLXVJR</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Yen M, Cairns LS, Camilli A. A cocktail of three virulent bacteriophages prevents Vibrio cholerae infection in animal models. Nat Commun. 2017;8:14187. https://doi.org/10.1038/ncomms14187</mixed-citation><mixed-citation xml:lang="en">Yen M, Cairns LS, Camilli A. A cocktail of three virulent bacteriophages prevents Vibrio cholerae infection in animal models. Nat Commun. 2017;8:14187. https://doi.org/10.1038/ncomms14187</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Тюрина А.В., Гаевская Н.Е., Иванова И.А., Филиппенко А.В., Омельченко Н.Д., и др. Оценка эффективности использования холерных бактериофагов для профилактики экспериментальной холеры. Проблемы особо опасных инфекций. 2024;(2):193-195.</mixed-citation><mixed-citation xml:lang="en">Tyurina A.V., Gaevskaya N.E., Ivanova I.A., Filippenko A.V., Omel’chenko N.D., Trufanova A.A., Pogozhova M.P., Anoprienko A.O., Sizova Yu.V., Pasyukova N.I. Assessment of the Effectiveness of Cholera Bacteriophages for Prevention of Experimental Cholera. Problems of Particularly Dangerous Infections. 2024;(2):193-195. (In Russ.) https://doi.org/10.21055/0370-1069-2024-2-193-195</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">De R Mobile Genetic Elements of Vibrio cholerae and the Evolution of Its Antimicrobial Resistanc Front.Trop. Dis. 2021;2:691604. https://doi.org/10.3389/fitd.2021.691604</mixed-citation><mixed-citation xml:lang="en">De R Mobile Genetic Elements of Vibrio cholerae and the Evolution of Its Antimicrobial Resistanc Front.Trop. Dis. 2021;2:691604. https://doi.org/10.3389/fitd.2021.691604</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Siriphap A, Kiddee A, Duangjai A, Yosboonruang A, Pook-In G, et al. Antimicrobial Activity of the Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG) against Clinical Isolates of Multidrug-Resistant Vibrio cholerae. Antibiotics (Basel). 2022;11(4):518. https://doi.org/10.3390/antibiotics11040518</mixed-citation><mixed-citation xml:lang="en">Siriphap A, Kiddee A, Duangjai A, Yosboonruang A, Pook-In G, et al. Antimicrobial Activity of the Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG) against Clinical Isolates of Multidrug-Resistant Vibrio cholerae. Antibiotics (Basel). 2022;11(4):518. https://doi.org/10.3390/antibiotics11040518</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Kim HI, Kim JA, Choi EJ, Harris JB, Jeong SY, et al. In vitro and in vivo antimicrobial efficacy of natural plant-derived compounds against Vibrio cholerae of O1 El Tor Inaba serotype. Biosci Biotechnol Biochem. 2015;79(3):475-83. https://doi.org/10.1080/09168451.2014.991685</mixed-citation><mixed-citation xml:lang="en">Kim HI, Kim JA, Choi EJ, Harris JB, Jeong SY, et al. In vitro and in vivo antimicrobial efficacy of natural plant-derived compounds against Vibrio cholerae of O1 El Tor Inaba serotype. Biosci Biotechnol Biochem. 2015;79(3):475-83. https://doi.org/10.1080/09168451.2014.991685</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Paredes A, Leyton Y, Riquelme C, Morales G. A plant from the altiplano of Northern Chile Senecio nutans, inhibits the Vibrio cholerae pathogen. Springerplus. 2016;5(1):1788. https://doi.org/10.1186/s40064-016-3469-6</mixed-citation><mixed-citation xml:lang="en">Paredes A, Leyton Y, Riquelme C, Morales G. A plant from the altiplano of Northern Chile Senecio nutans, inhibits the Vibrio cholerae pathogen. Springerplus. 2016;5(1):1788. https://doi.org/10.1186/s40064-016-3469-6</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Shittu OB, Ajayi OL, Bankole SO, Popoola TO. Intestinal ameliorative effects of traditional Ogi-tutu, Vernonia amygdalina and Psidium guajava in mice infected with Vibrio cholera. Afr Health Sci. 2016;16(2):620-628. https://doi.org/10.4314/ahs.v16i2.33</mixed-citation><mixed-citation xml:lang="en">Shittu OB, Ajayi OL, Bankole SO, Popoola TO. Intestinal ameliorative effects of traditional Ogi-tutu, Vernonia amygdalina and Psidium guajava in mice infected with Vibrio cholera. Afr Health Sci. 2016;16(2):620-628. https://doi.org/10.4314/ahs.v16i2.33</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Renzetti A, Betts JW, Fukumoto K, Rutherford RN Antibacterial green tea catechins from a molecular perspective: mechanisms of action and structure-activity relationships. Food Funct. 2020;18;11(11):9370-9396. https://doi.org/10.1039/d0fo02054k</mixed-citation><mixed-citation xml:lang="en">Renzetti A, Betts JW, Fukumoto K, Rutherford RN Antibacterial green tea catechins from a molecular perspective: mechanisms of action and structure-activity relationships. Food Funct. 2020;18;11(11):9370-9396. https://doi.org/10.1039/d0fo02054k</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Wu M, Brown AC. Applications of Catechins in the Treatment of Bacterial Infections. Pathogens. 2021;10(5):546. https://doi.org/10.3390/pathogens10050546</mixed-citation><mixed-citation xml:lang="en">Wu M, Brown AC. Applications of Catechins in the Treatment of Bacterial Infections. Pathogens. 2021;10(5):546. https://doi.org/10.3390/pathogens10050546</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Bhattacharya D, Sinha R, Mukherjee P, Howlader DR, Nag D, et al. Anti-virulence activity of polyphenolic fraction isolated from Kombucha against Vibrio cholerae. Microb Pathog. 2020;140:103927. https://doi.org/10.1016/j.micpath.2019.103927</mixed-citation><mixed-citation xml:lang="en">Bhattacharya D, Sinha R, Mukherjee P, Howlader DR, Nag D, et al. Anti-virulence activity of polyphenolic fraction isolated from Kombucha against Vibrio cholerae. Microb Pathog. 2020;140:103927. https://doi.org/10.1016/j.micpath.2019.103927</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Bag PK, Roy N, Acharyya S, Saha DR, Koley H, et al. In vivo fluid accumulation-inhibitory, anticolonization and anti-inflammatory and in vitro biofilm-inhibitory activities of methyl gallate isolated from Terminalia chebula against fluoroquinolones resistant Vibrio cholerae. Microb Pathog. 2019;128:41-46. https://doi.org/10.1016/j.micpath.2018.12.037</mixed-citation><mixed-citation xml:lang="en">Bag PK, Roy N, Acharyya S, Saha DR, Koley H, et al. In vivo fluid accumulation-inhibitory, anticolonization and anti-inflammatory and in vitro biofilm-inhibitory activities of methyl gallate isolated from Terminalia chebula against fluoroquinolones resistant Vibrio cholerae. Microb Pathog. 2019;128:41-46. https://doi.org/10.1016/j.micpath.2018.12.037</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Vasanth S, Mohanraj RS, Mandal J. In-vitro study of the effect of Centella asiatica on cholera toxin production and the gene expression level of ctxA gene in Vibrio cholerae isolates. J Ethnopharmacol. 2021;279:113930. https://doi.org/10.1016/j.jep.2021.113930</mixed-citation><mixed-citation xml:lang="en">Vasanth S, Mohanraj RS, Mandal J. In-vitro study of the effect of Centella asiatica on cholera toxin production and the gene expression level of ctxA gene in Vibrio cholerae isolates. J Ethnopharmacol. 2021;279:113930. https://doi.org/10.1016/j.jep.2021.113930</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Ghannay S, Aouadi K, Kadri A, Snoussi M. In Vitro and In Silico Screening of Anti-Vibrio spp., Antibiofilm, Antioxidant and Anti-Quorum Sensing Activities of Cuminum cyminum L. Volatile Oil. Plants (Basel). 2022;11(17):2236. https://doi.org/10.3390/plants11172236</mixed-citation><mixed-citation xml:lang="en">Ghannay S, Aouadi K, Kadri A, Snoussi M. In Vitro and In Silico Screening of Anti-Vibrio spp., Antibiofilm, Antioxidant and Anti-Quorum Sensing Activities of Cuminum cyminum L. Volatile Oil. Plants (Basel). 2022;11(17):2236. https://doi.org/10.3390/plants11172236</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Charla R, Patil PP, Bhatkande AA, Khode NR, Balaganur V, et al. In Vitro and In Vivo Inhibitory Activities of Selected Traditional Medicinal Plants against Toxin-Induced Cyto- and Entero- Toxicities in Cholera. Toxins (Basel). 2022;14(10):649. https://doi.org/10.3390/toxins14100649</mixed-citation><mixed-citation xml:lang="en">Charla R, Patil PP, Bhatkande AA, Khode NR, Balaganur V, et al. In Vitro and In Vivo Inhibitory Activities of Selected Traditional Medicinal Plants against Toxin-Induced Cyto- and Entero- Toxicities in Cholera. Toxins (Basel). 2022;14(10):649. https://doi.org/10.3390/toxins14100649</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Charla R, Patil PP, Patil VS, Bhandare VV, Karoshi V, Balaganur V, Joshi RK, Harish DR, Roy S. Anti-Cholera toxin activity of selected polyphenols from Careya arborea, Punica granatum, and Psidium guajava. Front Cell Infect Microbiol. 2023;13:1106293. https://doi.org/10.3389/fcimb.2023.1106293</mixed-citation><mixed-citation xml:lang="en">Charla R, Patil PP, Patil VS, Bhandare VV, Karoshi V, Balaganur V, Joshi RK, Harish DR, Roy S. Anti-Cholera toxin activity of selected polyphenols from Careya arborea, Punica granatum, and Psidium guajava. Front Cell Infect Microbiol. 2023;13:1106293. https://doi.org/10.3389/fcimb.2023.1106293</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Calzada F, Juárez T, García-Hernández N, Valdes M, Ávila O, et al. Antiprotozoal, Antibacterial and Antidiarrheal Properties from the Flowers of Chiranthodendron pentadactylon and Isolated Flavonoids. Pharmacogn Mag. 2017;13(50):240-244. https://doi.org/10.4103/0973-1296.204564</mixed-citation><mixed-citation xml:lang="en">Calzada F, Juárez T, García-Hernández N, Valdes M, Ávila O, et al. Antiprotozoal, Antibacterial and Antidiarrheal Properties from the Flowers of Chiranthodendron pentadactylon and Isolated Flavonoids. Pharmacogn Mag. 2017;13(50):240-244. https://doi.org/10.4103/0973-1296.204564</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Pederson DB, Dong Y, Blue LB, Smith SV, Cao M. Water-soluble cranberry extract inhibits Vibrio cholerae biofilm formation possibly through modulating the second messenger 3', 5' - Cyclic diguanylate level. PLoS One. 2018;13(11):e0207056. https://doi.org/10.1371/journal.pone.0207056</mixed-citation><mixed-citation xml:lang="en">Pederson DB, Dong Y, Blue LB, Smith SV, Cao M. Water-soluble cranberry extract inhibits Vibrio cholerae biofilm formation possibly through modulating the second messenger 3', 5' - Cyclic diguanylate level. PLoS One. 2018;13(11):e0207056. https://doi.org/10.1371/journal.pone.0207056</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Acosta-Smith E, Leon-Sicairos N, Tiwari S, Flores-Villaseñor H, Canizalez-Roman A, et al. Piper betel Compounds Piperidine, Eugenyl Acetate, and Chlorogenic Acid Are BroadSpectrum Anti-Vibrio Compounds that Are Also Effective on MDR Strains of the Pathogen. Pathogens. 2019;8(2):64. https://doi.org/10.3390/pathogens8020064</mixed-citation><mixed-citation xml:lang="en">Acosta-Smith E, Leon-Sicairos N, Tiwari S, Flores-Villaseñor H, Canizalez-Roman A, et al. Piper betel Compounds Piperidine, Eugenyl Acetate, and Chlorogenic Acid Are BroadSpectrum Anti-Vibrio Compounds that Are Also Effective on MDR Strains of the Pathogen. Pathogens. 2019;8(2):64. https://doi.org/10.3390/pathogens8020064</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Das S, Chourashi R, Mukherjee P, Kundu S, Koley H, et al. Inhibition of growth and virulence of Vibrio cholerae by carvacrol, an essential oil component of Origanum spp. J Appl Microbiol. 2021;131(3):1147-1161. https://doi.org/10.1111/jam.15022</mixed-citation><mixed-citation xml:lang="en">Das S, Chourashi R, Mukherjee P, Kundu S, Koley H, et al. Inhibition of growth and virulence of Vibrio cholerae by carvacrol, an essential oil component of Origanum spp. J Appl Microbiol. 2021;131(3):1147-1161. https://doi.org/10.1111/jam.15022</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Suriyaprom S, Kaewkod T, Promputtha I, Desvaux M, Tragoolpua Y. Evaluation of Antioxidant and Antibacterial Activities of White Mulberry (Morus alba L.) Fruit Extracts. Plants (Basel). 2021;10(12):2736. https://doi.org/10.3390/plants10122736</mixed-citation><mixed-citation xml:lang="en">Suriyaprom S, Kaewkod T, Promputtha I, Desvaux M, Tragoolpua Y. Evaluation of Antioxidant and Antibacterial Activities of White Mulberry (Morus alba L.) Fruit Extracts. Plants (Basel). 2021;10(12):2736. https://doi.org/10.3390/plants10122736</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Okuda S, Wajima T, Yamada T, Nakaminami H, Ikoshi H, Noguchi N. In vitro growth-inhibitory effects of Portulaca oleracea L. formulation on intestinal pathogens. Access Microbiol. 2021;3(3):000208. https://doi.org/10.1099/acmi.0.000208</mixed-citation><mixed-citation xml:lang="en">Okuda S, Wajima T, Yamada T, Nakaminami H, Ikoshi H, Noguchi N. In vitro growth-inhibitory effects of Portulaca oleracea L. formulation on intestinal pathogens. Access Microbiol. 2021;3(3):000208. https://doi.org/10.1099/acmi.0.000208</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Arora S, Sharma A. Exploring the Role of Mentha in Gut Microbiota: A Modern Perspective of an Ancient Herb. Recent Adv Food Nutr Agric. 2023;14(2):94-106. https://doi.org/10.2174/2772574X14666230411101712</mixed-citation><mixed-citation xml:lang="en">Arora S, Sharma A. Exploring the Role of Mentha in Gut Microbiota: A Modern Perspective of an Ancient Herb. Recent Adv Food Nutr Agric. 2023;14(2):94-106. https://doi.org/10.2174/2772574X14666230411101712</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Woodbrey AK, Onyango EO, Pellegrini M, Kovacikova G, Taylor RK, et al. A new class of inhibitors of the AraC family virulence regulator Vibrio cholerae ToxT. Sci Rep. 2017;7:45011. https://doi.org/10.1038/srep45011</mixed-citation><mixed-citation xml:lang="en">Woodbrey AK, Onyango EO, Pellegrini M, Kovacikova G, Taylor RK, et al. A new class of inhibitors of the AraC family virulence regulator Vibrio cholerae ToxT. Sci Rep. 2017;7:45011. https://doi.org/10.1038/srep45011</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Das S, Angsantikul P, Le C, Bao D, Miyamoto Y, et al. Neutralization of cholera toxin with nanoparticle decoys for treatment of cholera. PLoS Negl Trop Dis. 2018;12(2):e0006266. https://doi.org/10.1371/journal.pntd.0006266</mixed-citation><mixed-citation xml:lang="en">Das S, Angsantikul P, Le C, Bao D, Miyamoto Y, et al. Neutralization of cholera toxin with nanoparticle decoys for treatment of cholera. PLoS Negl Trop Dis. 2018;12(2):e0006266. https://doi.org/10.1371/journal.pntd.0006266</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Collin F, Maxwell A. The Microbial Toxin Microcin B17: Prospects for the Development of New Antibacterial Agents. J Mol Biol. 2019;431(18):3400-3426. https://doi.org/10.1016/j.jmb.2019.05.050</mixed-citation><mixed-citation xml:lang="en">Collin F, Maxwell A. The Microbial Toxin Microcin B17: Prospects for the Development of New Antibacterial Agents. J Mol Biol. 2019;431(18):3400-3426. https://doi.org/10.1016/j.jmb.2019.05.050</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Kim SY, Randall JR, Gu R, Nguyen QD, Davies BW. Antibacterial action, proteolytic immunity, and in vivo activity of a Vibrio cholerae microcin. Cell Host Microbe. 2024;32(11):1959-1971.e6. https://doi.org/10.1016/j.chom.2024.08.012</mixed-citation><mixed-citation xml:lang="en">Kim SY, Randall JR, Gu R, Nguyen QD, Davies BW. Antibacterial action, proteolytic immunity, and in vivo activity of a Vibrio cholerae microcin. Cell Host Microbe. 2024;32(11):1959-1971.e6. https://doi.org/10.1016/j.chom.2024.08.012</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Bahroudi M, Bakhshi B, Soudi S, Najar-Peerayeh S. Antibacterial and antibiofilm activity of bone marrow-derived human mesenchymal stem cells secretome against Vibrio cholerae. Microb Pathog. 2020;139:103867. https://doi.org/10.1016/j.micpath.2019.103867</mixed-citation><mixed-citation xml:lang="en">Bahroudi M, Bakhshi B, Soudi S, Najar-Peerayeh S. Antibacterial and antibiofilm activity of bone marrow-derived human mesenchymal stem cells secretome against Vibrio cholerae. Microb Pathog. 2020;139:103867. https://doi.org/10.1016/j.micpath.2019.103867</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Sarwar S, Ali A, Pal M, Chakrabarti P. Zinc oxide nanoparticles provide anti-cholera activity by disrupting the interaction of cholera toxin with the human GM1 receptor. J Biol Chem. 2017;292(44):18303-18311. https://doi.org/10.1074/jbc.M117.793240</mixed-citation><mixed-citation xml:lang="en">Sarwar S, Ali A, Pal M, Chakrabarti P. Zinc oxide nanoparticles provide anti-cholera activity by disrupting the interaction of cholera toxin with the human GM1 receptor. J Biol Chem. 2017;292(44):18303-18311. https://doi.org/10.1074/jbc.M117.793240</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Jana SK, Gucchait A, Paul S, Saha T, Acharya S, et al. VirstatinConjugated Gold Nanoparticle with Enhanced Antimicrobial Activity against the Vibrio cholerae El Tor Biotype. ACS Appl Bio Mater. 2021;4(4):3089-3100. https://doi.org/10.1021/acsabm.0c01483</mixed-citation><mixed-citation xml:lang="en">Jana SK, Gucchait A, Paul S, Saha T, Acharya S, et al. VirstatinConjugated Gold Nanoparticle with Enhanced Antimicrobial Activity against the Vibrio cholerae El Tor Biotype. ACS Appl Bio Mater. 2021;4(4):3089-3100. https://doi.org/10.1021/acsabm.0c01483</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Shikha S, Kumar V, Jain A, Dutta D. Bhattacharyya MS. Unraveling the mechanistic insights of sophorolipid-capped gold nanoparticle-induced cell death in Vibrio cholerae. Microbiol Spectr. 2023;11(6):e0017523. https://doi.org/10.1128/spectrum.00175-23</mixed-citation><mixed-citation xml:lang="en">Shikha S, Kumar V, Jain A, Dutta D. Bhattacharyya MS. Unraveling the mechanistic insights of sophorolipid-capped gold nanoparticle-induced cell death in Vibrio cholerae. Microbiol Spectr. 2023;11(6):e0017523. https://doi.org/10.1128/spectrum.00175-23</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
